Literature DB >> 11861677

Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins.

Kevin P Dwyer1, P Hugh R Barrett, Dick Chan, Jock I Foo, Gerald F Watts, Kevin D Croft.   

Abstract

Stable isotope labeled amino acids are commonly used as endogenous tracers to study the metabolism of lipoproteins. The determination of isotopic enrichment of particular amino acids in apolipoproteins is carried out by gas chromatography mass spectrometry (GC-MS). This report describes a robust and sensitive derivative for analysis of d3-leucine by GC-MS and its utility in studying the metabolism of human lipoproteins. The trifluoromethyloxazolinone (oxazolinone) derivative of leucine was formed in a rapid single step procedure using a mixture of trifluoroacetic anhydride (TFAA) and trifluoroacetic acid (TFA). Analysis of the oxazolinone by negative ion chemical ionization GC-MS gave excellent sensitivity and precision, which enabled accurate determination of low levels of isotopic enrichment from small amounts of protein. For example, enrichments between 0.05% and 100% in 100 pg leucine can be measured with a coefficient of variation of <3%. To demonstrate the utility of this procedure, we measured d3-leucine enrichment in apolipoprotein B (apoB) isolated from VLDL and LDL as well as apoA-I isolated from HDL by gel electrophoresis and western blotting. The derivatization procedure gave excellent enrichment data from a single intravenous bolus dose of 5 mg/kg, from which the fractional catabolic rate and production rate of the lipoproteins were calculated. In conclusion, the oxazolinone derivative provides a robust and simple procedure for the sensitive analysis of isotopic enrichment for metabolic studies of human lipoproteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861677

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Quantifying apoprotein synthesis in rodents: coupling LC-MS/MS analyses with the administration of labeled water.

Authors:  Haihong Zhou; Wenyu Li; Sheng-Ping Wang; Vivienne Mendoza; Raymond Rosa; James Hubert; Kithsiri Herath; Theresa McLaughlin; Rory J Rohm; Michael E Lassman; Kenny K Wong; Douglas G Johns; Stephen F Previs; Brian K Hubbard; Thomas P Roddy
Journal:  J Lipid Res       Date:  2012-03-03       Impact factor: 5.922

2.  Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins.

Authors:  Stefania Lamon-Fava; Margaret R Diffenderfer; P Hugh R Barrett; Aaron Buchsbaum; Mawuli Nyaku; Katalin V Horvath; Bela F Asztalos; Seiko Otokozawa; Masumi Ai; Nirupa R Matthan; Alice H Lichtenstein; Gregory G Dolnikowski; Ernst J Schaefer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-19       Impact factor: 8.311

3.  Development of a method to measure preβHDL and αHDL apoA-I enrichment for stable isotopic studies of HDL kinetics.

Authors:  Xuefei Li; Michael Stolinski; A Margot Umpleby
Journal:  Lipids       Date:  2012-08-11       Impact factor: 1.880

4.  Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism.

Authors:  Dick C Chan; Minh N Nguyen; Gerald F Watts; P Hugh R Barrett
Journal:  J Clin Endocrinol Metab       Date:  2007-11-13       Impact factor: 5.958

5.  Both intestinal and hepatic lipoprotein production are stimulated by an acute elevation of plasma free fatty acids in humans.

Authors:  Hélène Duez; Benoît Lamarche; René Valéro; Mirjana Pavlic; Spencer Proctor; Changting Xiao; Linda Szeto; Bruce W Patterson; Gary F Lewis
Journal:  Circulation       Date:  2008-04-28       Impact factor: 29.690

6.  Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.

Authors:  Dick C Chan; P Hugh R Barrett; Gerald F Watts
Journal:  Clin Biochem Rev       Date:  2004-02

7.  Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.

Authors:  Patrick Couture; André J Tremblay; Isabelle Kelly; Valéry Lemelin; Arnaud Droit; Benoît Lamarche
Journal:  J Lipid Res       Date:  2013-10-18       Impact factor: 5.922

8.  Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III.

Authors:  Doris T Chan; Gursharan K Dogra; Ashley B Irish; Esther M Ooi; P Hugh Barrett; Dick C Chan; Gerald F Watts
Journal:  J Lipid Res       Date:  2009-06-21       Impact factor: 5.922

9.  Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.

Authors:  Margaret E Brousseau; John S Millar; Margaret R Diffenderfer; Chorthip Nartsupha; Bela F Asztalos; Megan L Wolfe; James P Mancuso; Andres G Digenio; Daniel J Rader; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2009-02-03       Impact factor: 5.922

10.  Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia.

Authors:  André J Tremblay; Benoît Lamarche; Jean-Charles Hogue; Patrick Couture
Journal:  J Lipid Res       Date:  2009-03-22       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.